These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38068252)

  • 1. Soluble Suppression of Tumorigenicity 2 (sST2) in Patients with Predominantly Decompensated Right Heart Failure-A Prospective Observational Study.
    Dworok V; Hähnel V; Bannehr M; Paar V; Edlinger C; Lichtenauer M; Butter C; Haase-Fielitz A
    J Clin Med; 2023 Nov; 12(23):. PubMed ID: 38068252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Not Available].
    Protasov VN; Narusov OY; Skvortsov AA; Protasova DE; Kuznetsova TV; Petrukhina AA; Masenko VP; Tereshchenko SN
    Kardiologiia; 2019 Jan; 59(1S):53-64. PubMed ID: 30706839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Soluble Suppression of Tumorogenicity 2 Increases Opportunities for Risk Stratification After Acute Heart Failure Decompensation].
    Skvortsov AA; Protasov VN; Narusov OY; Koshkina DE; Nasonova SN; Masenko VP; Tereschenko SN
    Kardiologiia; 2017 Jan; (1):48-58. PubMed ID: 28290833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Value of β1 Adrenergic Receptor Autoantibody and Soluble Suppression of Tumorigenicity-2 in Patients With Acutely Decompensated Heart Failure.
    Sun Y; Feng L; Hu B; Dong J; Zhang L; Huang X; Yuan Y
    Front Cardiovasc Med; 2022; 9():821553. PubMed ID: 35224052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. sST2 Predicts Outcome in Chronic Heart Failure Beyond NT-proBNP and High-Sensitivity Troponin T.
    Emdin M; Aimo A; Vergaro G; Bayes-Genis A; Lupón J; Latini R; Meessen J; Anand IS; Cohn JN; Gravning J; Gullestad L; Broch K; Ueland T; Nymo SH; Brunner-La Rocca HP; de Boer RA; Gaggin HK; Ripoli A; Passino C; Januzzi JL
    J Am Coll Cardiol; 2018 Nov; 72(19):2309-2320. PubMed ID: 30384887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superior prognostic value of soluble suppression of tumorigenicity 2 for the short-term mortality of maintenance hemodialysis patients compared with NT-proBNP: a prospective cohort study.
    Wang Z; Chen Z; Yu H; Ma X; Zhang C; Qu B; Zhang W; Chen X
    Ren Fail; 2020 Nov; 42(1):523-530. PubMed ID: 32460670
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of intravenous furosemide plus small-volume hypertonic saline solutions on markers of heart failure.
    Tuttolomondo A; Maida C; Casuccio A; Di Raimondo D; Fonte R; Vassallo V; Puleo MG; Di Chiara T; Mogavero A; Del Cuore A; Daidone M; Ortello A; Pinto A
    ESC Heart Fail; 2021 Oct; 8(5):4174-4186. PubMed ID: 34288546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating levels and prognostic cut-offs of sST2, hs-cTnT, and NT-proBNP in women vs. men with chronic heart failure.
    Vergaro G; Gentile F; Aimo A; Januzzi JL; Richards AM; Lam CSP; de Boer RA; Meems LMG; Latini R; Staszewsky L; Anand IS; Cohn JN; Ueland T; Gullestad L; Aukrust P; Brunner-La Rocca HP; Bayes-Genis A; Lupón J; Yoshihisa A; Takeishi Y; Egstrup M; Gustafsson I; Gaggin HK; Eggers KM; Huber K; Gamble GD; Ling LH; Leong KTG; Yeo PSD; Ong HY; Jaufeerally F; Ng TP; Troughton R; Doughty RN; Devlin G; Lund M; Giannoni A; Passino C; Emdin M
    ESC Heart Fail; 2022 Aug; 9(4):2084-2095. PubMed ID: 35510529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of chronic heart failure by the soluble suppression of tumorigenicity 2 and N-terminal pro-brain natriuretic peptide.
    Jin XL; Huang N; Shang H; Zhou MC; Hong Y; Cai WZ; Huang J
    J Clin Lab Anal; 2018 Mar; 32(3):. PubMed ID: 28719009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating levels and prognostic value of soluble ST2 in heart failure are less influenced by age than N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T.
    Aimo A; Januzzi JL; Vergaro G; Richards AM; Lam CSP; Latini R; Anand IS; Cohn JN; Ueland T; Gullestad L; Aukrust P; Brunner-La Rocca HP; Bayes-Genis A; Lupón J; de Boer RA; Takeishi Y; Egstrup M; Gustafsson I; Gaggin HK; Eggers KM; Huber K; Gamble GD; Ling LH; Leong KTG; Yeo PSD; Ong HY; Jaufeerally F; Ng TP; Troughton R; Doughty RN; Passino C; Emdin M
    Eur J Heart Fail; 2020 Nov; 22(11):2078-2088. PubMed ID: 31919929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Diagnostic Accuracy of N-Terminal Pro-B-Type Natriuretic Peptide and Soluble ST2 for Heart Failure in Chronic Kidney Disease Patients: A Comparative Analysis.
    Ma H; Zhou J; Zhang M; Shen C; Jiang Z; Zhang T; Gao F
    Med Sci Monit; 2023 Sep; 29():e940641. PubMed ID: 37667469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The utility of inferior vena cava diameter and the degree of inspiratory collapse in patients with systolic heart failure.
    Besli F; Kecebas M; Caliskan S; Dereli S; Baran I; Turker Y
    Am J Emerg Med; 2015 May; 33(5):653-7. PubMed ID: 25704186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical significance of combined sST2 and NT-proBNP detection for the short-term prognosis of acute organophosphorus pesticide poisoning].
    Chen J; Zhu J; Liu XT; Wang L; Qi HN; Ma GY
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2021 Sep; 39(9):671-674. PubMed ID: 34624949
    [No Abstract]   [Full Text] [Related]  

  • 14. Circulating sST2 and catestatin levels in patients with acute worsening of heart failure: a report from the CATSTAT-HF study.
    Borovac JA; Glavas D; Susilovic Grabovac Z; Supe Domic D; Stanisic L; D'Amario D; Kwok CS; Bozic J
    ESC Heart Fail; 2020 Oct; 7(5):2818-2828. PubMed ID: 32681700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Angiotensin Receptor-Neprilysin Inhibition, Cardiovascular Biomarkers, and Cardiac Remodeling in Heart Failure With Reduced Ejection Fraction.
    Murphy SP; Prescott MF; Maisel AS; Butler J; Piña IL; Felker GM; Ward JH; Williamson KM; Camacho A; Kandanelly RR; Solomon SD; Januzzi JL
    Circ Heart Fail; 2021 Jun; 14(6):e008410. PubMed ID: 33998243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ST2 elevation in heart failure, predictive of a high early mortality.
    Dalal JJ; Digrajkar A; Das B; Bansal M; Toomu A; Maisel AS
    Indian Heart J; 2018; 70(6):822-827. PubMed ID: 30580851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Predictive value of early detection of hs-cTnI and sST2 for secondary cardiac damage in severe acute organophosphorus pesticide poisoning].
    Liu XT; Wang L; Chen J; Qi HN; Ma GY
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2020 Apr; 38(4):241-245. PubMed ID: 32447883
    [No Abstract]   [Full Text] [Related]  

  • 18. Suppression of Tumorigenicity 2 in Heart Failure With Preserved Ejection Fraction.
    AbouEzzeddine OF; McKie PM; Dunlay SM; Stevens SR; Felker GM; Borlaug BA; Chen HH; Tracy RP; Braunwald E; Redfield MM
    J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28214792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased Plasma Concentrations of Soluble ST2 Independently Predict Mortality but not Cardiovascular Events in Stable Coronary Heart Disease Patients: 13-Year Follow-up of the KAROLA Study.
    Pfetsch V; Sanin V; Jaensch A; Dallmeier D; Mons U; Brenner H; Koenig W; Rothenbacher D
    Cardiovasc Drugs Ther; 2017 Apr; 31(2):167-177. PubMed ID: 28283847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial fibrosis combined with NT-proBNP improves the accuracy of survival prediction in ADHF patients.
    Yao Y; Feng L; Sun Y; Wang S; Sun J; Hu B
    BMC Cardiovasc Disord; 2021 May; 21(1):264. PubMed ID: 34049488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.